1. United Kingdom Stocks

  2. •

    Technology services

  3. •

    Packaged software
Craneware plc

Craneware plc

13.10
EUR
0.00
(0.00%)
904.16MMarket Cap
Mar 08Next Earn
Craneware plc
DUS:3X6
(Dusseldorf Stock Exchange)

Recent

price

13.10

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
USD
1.46
1.52
1.54
1.58
1.67
1.86
2.15
2.5
2.68
2.67
2.82
4.72
4.95
5.41
- -
- -
- -
Revenue per Share
0.23
0.33
0.31
0.32
0.35
0.39
0.5
0.59
0.56
0.63
0.48
0.27
0.26
0.33
- -
- -
- -
Basic EPS, GAAP
0.25
0.32
0.23
0.28
0.69
0.48
0.49
0.94
0.11
0.4
0.87
0.76
2.79
1.16
- -
- -
- -
Free Cash Flow per Basic Share
0.12
0.15
0.17
0.2
0.2
0.22
0.24
0.29
0.32
0.34
0.36
0.37
0.34
0.37
- -
- -
- -
Dividend per Share
1.21
1.39
1.53
1.66
1.78
1.97
2.2
1.94
2.24
2.55
7.88
9.37
9.28
9.3
- -
- -
9.29
Book Value per Share
0.59
0.79
0.96
1.13
1.17
1.35
1.47
1.06
1.1
1.18
6.58
-3.74
-3.51
-3.08
- -
- -
-2.83
Tangible Book Value per Share
26
27
27
27
27
27
27
27
27
27
27
35
35
35
35
35
35
Basic Weighted Avg Shares
38
41
41
43
45
50
58
67
71
71
76
166
174
189
- -
- -
- -
Sales/Revenue/Turnover
23.9
24.64
25.58
26.47
28.05
28.91
28.55
27.72
26.95
26.88
26.16
11.23
9.86
11.01
- -
- -
- -
Operating Margin (%)
1
2
2
2
1
2
1
2
4
5
5
29
32
33
- -
- -
- -
Depreciation Expense
6
9
8
9
9
11
14
16
15
17
13
9
9
12
- -
- -
- -
Net Income, GAAP
30.49
20.61
21.76
23.74
24.87
24.05
19.89
16.56
18.21
12.78
1.97
28.19
29.45
25.68
- -
- -
- -
Effective Tax Rate (%)
15.78
21.65
20.01
20.22
20.95
21.22
23.4
23.55
20.99
23.55
17.08
5.68
5.31
6.18
- -
- -
- -
Profit Margin (%)
14
18
23
28
27
29
31
18
20
24
206
10
-13
-56
- -
- -
-51
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
1
105
77
31
- -
- -
27
LT Debt
32
37
41
45
48
53
59
52
60
68
260
333
328
329
- -
- -
329
Total Equity
21.92
25
20.43
19.64
19.94
20.54
23.73
28.65
26.69
25.76
7.81
3.7
3.17
3.74
- -
- -
- -
Return on Invested Capital (%)
22.09
25.47
21.07
19.97
20.29
21.06
24.12
28.46
26.88
25.79
7.78
3.66
3.18
3.96
- -
- -
- -
Return on Capital (%)
22.09
25.47
21.07
19.97
20.29
21.06
24.12
28.46
26.88
26.26
7.85
3.17
2.79
3.57
- -
- -
- -
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Dec'24
Jun'24
Dec'25
ST Debt
9
9
9
LT Borrowings
51
27
24
LT Finance Leases
2
4
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
35
35
35
Market Capitalization
- -
984
936

Working Capital

USD

•

in mil. unless spec.
Dec'24
Jun'24
Dec'25
Total Current Assets
119
93
126
Cash, Cash Equivalents & STI
64
35
72
Accounts Receivable, Net
41
45
35
Inventories
- -
- -
- -
Total Current Liabilities
154
149
177
Payables & Accruals
- -
- -
- -
ST Debt
9
9
9
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
189
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Earnings Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.33
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Dividends Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.37
2025
- -
- -
- -
2026
- -
- -
- -
Similar Companies
Microsoft Corporation (NASDAQ:MSFT)
Palantir Technologies Inc. (NASDAQ:PLTR)
Nebius Group N.V. (NASDAQ:NBIS)
Oracle Corporation (NYSE:ORCL)
CoreWeave, Inc. (NASDAQ:CRWV)
ServiceNow, Inc. (NYSE:NOW)
Business
Craneware plc (LSE: CRW) develops and provides mission-critical SaaS solutions for the healthcare sector, with a primary focus on revenue integrity, patient engagement, and financial performance management for hospitals and health systems. The company offers a comprehensive suite of products including Trisus Revenue Cycle, its flagship platform for end-to-end revenue cycle management; ChargeTRUE for automated charge capture and compliance; Trisus Decision Analytics for data-driven insights; Patient Engagement Portal for streamlined billing and payments; and Value Analytics for optimizing reimbursement strategies; as well as services encompassing implementation, training, managed services, and ongoing support. Craneware primarily serves acute care hospitals, integrated delivery networks, and children's hospitals in the United States, its core market, with expanding operations in the United Kingdom and select international regions. Founded in 1996 and headquartered in Edinburgh, Scotland, the company operates as a standalone entity listed on the London Stock Exchange's AIM market. In recent developments, Craneware completed the acquisition of Clinion in late 2023, enhancing its pharmacy revenue integrity capabilities and marking a strategic expansion into specialized clinical workflows. The company reported robust growth in fiscal 2025, driven by strong recurring SaaS revenue and new client wins, including major U.S. health systems adopting its Trisus platform amid rising demand for revenue optimization tools. Additionally, Craneware announced partnerships with leading electronic health record (EHR) providers to integrate its solutions more seamlessly, supporting broader adoption in value-based care environments.

Company News

Company News APIChatGPT

  • seekingalpha.com

    Craneware plc (CRWRF) Q4 2026 Earnings Call Transcript

  • proactiveinvestors.com

    Craneware sinks 25% as Peel Hunt cuts forecasts after cyber warning

  • proactiveinvestors.com

    Craneware resets revenue expectations to $185 million after cyber incident as profit rises

  • defenseworld.net

    Craneware (OTCMKTS:CRWRF) Stock Price Down 2.2% – What’s Next?

  • proactiveinvestors.co.uk

    Craneware reveals cyber attack with employee and customer data stolen

  • proactiveinvestors.co.uk

    Craneware shares slump after slower conversion triggers profit warning

  • seekingalpha.com

    Craneware plc (CRWRF) Q2 2026 Earnings Call Prepared Remarks Transcript

  • defenseworld.net

    Craneware (OTCMKTS:CRWRF) Trading Down 24.5% – What’s Next?